CLINICAL_TRIALS
trial_result
· 2018-12-07
Clinical Trial Update: Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia. [Phase 3]
Summary
Phase 3 clinical trial update on the safety and efficacy of zirconium silicate for 28 days in hyperkalemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ZS Pharma, Inc. | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2018-12-07